drugset / Trial / NCT01961739

Topical 2% Lidocaine for the Treatment of Symptomatic Hemorrhoids

NCT01961739

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this study is to evaluate the efficacy of topical 2% lidocaine in the therapy of symptomatic hemorrhoids. Efficacy will be determined by: 1. the change from baseline in pain, itching, bleeding, swelling, discomfort, general well-being and improvement since the beginning of treatment as separate components of CORRECTS scale 2. the change in overall CORRECTS values from baseline 3. the change in degree of hemorrhoids from baseline

Timeline

Start
2013-10
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 % Topical

Indications